Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evocalcet in Parathyroid Carcinoma and Primary Hyperparathyroidism
NCT03280264Phase 3Completed
- Sponsor
- Kyowa Kirin
- Start
- Aug 2017
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ASP7991 in parathyroid carcinoma, primary hyperparathyroidism (PHPT), sponsored by Kyowa Kirin. Started Aug 2017; status: completed.
02
Drugs
ASP7991
03
Conditions
parathyroid carcinomaprimary hyperparathyroidism (PHPT)
Beyond the preview
Go deeper on NCT03280264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03280264.